Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
SCHLIEMAN, M. G, FAHY, B. N, RAMSAMOOJ, R, BECKETT, L, BOLD, R. J
Published in British journal of cancer (01.12.2003)
Published in British journal of cancer (01.12.2003)
Get full text
Journal Article
AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2
FAHY, B. N, SCHLIEMAN, M, VIRUDACHALAM, S, BOLD, R. J
Published in British journal of cancer (21.07.2003)
Published in British journal of cancer (21.07.2003)
Get full text
Journal Article
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
Schlieman, M G, Fahy, B N, Ramsamooj, R, Beckett, L, Bold, R J
Published in British journal of cancer (01.12.2003)
Published in British journal of cancer (01.12.2003)
Get full text
Journal Article
Sentinel lymph node biopsy for breast cancer
BOLD, Richard J, SCHLIEMAN, Michael, FAHY, Bridget N
Published in Cancer biotherapy & radiopharmaceuticals (01.10.2001)
Published in Cancer biotherapy & radiopharmaceuticals (01.10.2001)
Get full text
Journal Article
Effects of the 26S proteasome inhibitor, bortezomib, on BCL-2 in small cell lung cancer: Implications for SWOG-0327
Mortenson, M. M., Schlieman, M. G., Virudachalam, S., Lara, P. N., Gandara, D. G., Davies, A. M., Bold, R. J.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Effects of the 26S proteasome inhibitor, bortezomib, on BCL-2 in small cell lung cancer: Implications for SWOG-0327
Mortenson, M. M., Schlieman, M. G., Virudachalam, S., Lara, P. N., Gandara, D. G., Davies, A. M., Bold, R. J.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Inhibition of AKT abrogates chemotherapy- induced NF-κB survival mechanisms: implications for therapy in pancreatic cancer
Fahy, Bridget N, Schlieman, Michael G, Virudachalam, Subbulakshmi, Bold, Richard J
Published in Journal of the American College of Surgeons (01.04.2004)
Published in Journal of the American College of Surgeons (01.04.2004)
Get full text
Journal Article
Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib
FAHY, Bridget N, SCHLIEMAN, Michael G, MORTENSON, Melinda M, VIRUDACHALAM, Subbulakshmi, BOLD, Richard J
Published in Cancer chemotherapy and pharmacology (01.07.2005)
Published in Cancer chemotherapy and pharmacology (01.07.2005)
Get full text
Journal Article
Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line
MORTENSON, Melinda M, SCHLIEMAN, Michael G, VIRUDACHALAM, Subbulakshmi, BOLD, Richard J
Published in Cancer chemotherapy and pharmacology (01.10.2004)
Published in Cancer chemotherapy and pharmacology (01.10.2004)
Get full text
Journal Article
Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer
Mortenson, Melinda M., Schlieman, Michael G., Virudachalam, Subbulakshmi, Lara, Primo N., Gandara, David G., Davies, Angela M., Bold, Richard J.
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2005)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2005)
Get full text
Journal Article
Utility of Tumor Markers in Determining Resectability of Pancreatic Cancer
Schlieman, Michael G, Ho, Hung S, Bold, Richard J
Published in Archives of surgery (Chicago. 1960) (01.09.2003)
Published in Archives of surgery (Chicago. 1960) (01.09.2003)
Get full text
Journal Article